-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the 12th, Shenzhou Cell announced that recently, the company’s holding subsidiary, Shenzhou Cell Engineering, received the "Drug Clinical Trial Approval" approved and issued by the State Food and Drug Administration.
SCTV01C is a recombinant new coronavirus Alpha+Beta mutant strain independently developed by Shenzhou Cell Engineering to address the problems of the first-generation domestic and foreign vaccines based on the original strain of the new coronavirus, such as the reduction of the neutralizing antibody titer and the protection rate of the mutant strain.